Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Summary

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic retinopathy.

Timeline

Start

2022-08-16

Primary completion

2024-08

Completion

2024-08

Outcome

Missed primary endpoint

release “Primary and secondary endpoints not met OPL-0401 demonstrated favorable safety profile” valohealth.com ↗

Drugs

Indications